|
|
||||||||
Physiologisches Institut, Justus-Liebig-Universität, D-35392 Giessen, Germany
| |
ABSTRACT |
|---|
|
|
|---|
When energy metabolism is disrupted, endothelial cells lose Ca2+ from endoplasmic reticulum (ER) and the cytosolic Ca2+ concentration ([Ca2+]i) increases. The importance of glycolytic energy production and the mechanism of Ca2+ loss from the ER were analyzed. Endothelial cells from porcine aorta in culture and in situ were used as models. 2-Deoxy-D-glucose (2-DG, 10 mM), an inhibitor of glycolysis, caused an increase in [Ca2+]i (measured with fura 2) within 1 min when total cellular ATP contents were not yet affected. Stimulation of oxidative energy production with pyruvate (5 mM) did not attenuate this 2-DG-induced rise of [Ca2+]i, while this maneuver preserved cellular ATP contents. The inhibitor of ER-Ca2+-ATPase, thapsigargin (10 nM), augmented the 2-DG-induced rise of [Ca2+]i. Xestospongin C (3 µM), an inhibitor of D-myo-inositol 3-phosphate [Ins(3)P]-sensitive ER-Ca2+ release, abolished the rise. The results demonstrate that the ER of endothelial cells is very sensitive to glycolytic metabolic inhibition. When this occurs, the ER Ca2+ store is discharged by opening of the Ins(3)P-sensitive release channel. Xestospongin C can effectively suppress the early [Ca2+]i rise in metabolically inhibited endothelial cells.
D-myo-inositol 3-phosphate-sensitive Ca2+ release; ischemia; hypoxia; cytosolic Ca2+ concentration
| |
INTRODUCTION |
|---|
|
|
|---|
IN ENDOTHELIAL CELLS, as in other cells, cytosolic free Ca2+ concentration ([Ca2+]i) is controlled within narrow limits. On stimulation of endothelial cells by mediators (e.g., thrombin and histamine) (4, 9, 14) or by mechanical forces (e.g., shear stress) (1, 21), endothelial cells respond with an increase in [Ca2+]i due to an activation of the D-myo-inositol 3-phosphate [Ins(3)P]-sensitive Ca2+ release mechanism of the endoplasmic reticulum (ER). The elevated state of [Ca2+]i triggers a variety of cellular functions (5, 7). The return to control of [Ca2+]i is mediated by activation of ATP-dependent Ca2+ transport mechanisms of the ER and the plasma membrane.
An increase in [Ca2+]i may also occur under pathophysiological conditions, e.g., during hypoxia or ischemia, when endothelial cells start developing an energy deficit. The relationship between energy loss and rise of [Ca2+]i differs distinctly from that found in many other cell types. In cardiomyocytes, for example, [Ca2+]i rises only after extensive loss of high-energy phosphates (16). In former studies (19, 20), we found that in metabolically disturbed endothelial cells, changes in [Ca2+]i and permeability occur much earlier in time. Endothelial cells respond rapidly to inhibition of energy production with a biphasic increase in [Ca2+]i. An initial, sudden rise occurs when less than 30% of ATP reserves are lost (20). This rise is due to the release of Ca2+ from an endogenous store, the ER. Thereafter, a slow progressive increase of [Ca2+]i takes place because of an influx of Ca2+ from the extracellular space. The increase in [Ca2+]i can trigger a variety of intracellular signal transduction cascades, including those regulating the endothelial barrier function. The increase in [Ca2+]i and subsequent metabolic and functional changes were found to be reversible during the initial and the early part of the second phase of cytosolic Ca2+ overload (20). The responsiveness of endothelial Ca2+ homeostasis to moderate changes in the energy state may have important consequences for endothelial function in vivo, because endothelial cells can rapidly lose small amounts of ATP, e.g., in hypoxia (2, 26, 32) or under oxidative stress (13, 28).
The mechanism by which metabolic inhibition evokes the initial sudden Ca2+ release from ER in endothelial cells is only partly understood. In the present study, we investigated whether inhibition of cytoplasmic production of ATP through glycolysis was equally effective as an inhibitor of mitochondrial ATP production. We also studied whether the initial rise of [Ca2+]i upon metabolic inhibition is due to a reduction in Ca2+ sequestration into or an acceleration of Ca2+ release from the ER. Finally, we tried to prevent the [Ca2+]i rise in metabolically impaired endothelial cells.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Cell culture and endothelium in situ. Endothelial cells from porcine aorta were isolated and cultured as previously described (24). Confluent cultures of primary endothelial cells were trypsinized in PBS composed of (in mM) 137 NaCl, 2.7 KCl, 1.5 KH2PO4, and 8.0 Na2HPO4, at pH 7.4, supplemented with 0.05% (wt/vol) trypsin and 0.02% (wt/vol) EDTA, and seeded at a density of 7 × 104 cells/cm2 on glass coverslips or 30-mm culture dishes (Falcon-type 3001) for determination of nucleotide contents, respectively. Experiments were performed with confluent monolayers, 4 days after seeding. One additional set of experiments was carried out on endothelial cells shortly after their isolation. For this purpose, the newly isolated cells were seeded directly on the coverslip and allowed to attach during a 24-h period before use. The same set of experiments was also performed using fresh endothelium in situ on the aortic vessel wall. For this purpose, disks of 8-mm diameter were cut from porcine aorta, washed, and stored in cell culture medium 199 before use.
Determination of [Ca2+]i. [Ca2+]i was determined using the fluorescent Ca2+ indicator, fura 2. Endothelial cells cultured on round glass coverslips (diameter 25 mm) were incubated in medium 199 supplemented with 5% (vol/vol) newborn calf serum (NCS) (heat-inactivated for 10 min at 60°C) and the addition of 2.5 µM fura 2-acetoxymethyl ester (AM) at 20°C in the dark. After a 45-min incubation period, the extracellular fura 2-AM was removed by a washing step and a medium change with NCS (2% vol/vol, heat-inactivated)-supplemented HEPES buffer (composition as described in Experimental protocols). The coverslips were then mounted in a temperature-controlled incubation chamber adapted to the fluorescence microscope (IX 70, Olympus; Hamburg, Germany). To allow hydrolysis of the AM, cells were incubated for 20 min at 35°C in the same medium before measurements were started. Loading protocol of endothelium on aortic disks was the same, except that aortic disks were incubated for 60 min with fura 2-AM at a final concentration of 5 µM.
Fluorescence intensities for both excitation wavelengths were acquired in intervals of 6 s and averaged over 1 min. [Ca2+]i was analyzed using a TILL Photonics imaging system (Martinsried, Germany). During incubations, the excitation wavelength alternated between 340 and 380 nm. Emitted light was detected at 510 nm, and the background was corrected. Fura 2 fluorescence was calibrated according to the method described by Grynkiewicz et al. (12). For this purpose, the cells were exposed to 5 µM ionomycin in modified HEPES solution containing either 3 mM Ca2+ or 5 mM EGTA to obtain the maximum (Rmax) and the minimum (Rmin) of the ratio of fluorescence (R), respectively. [Ca2+]i was calculated according to the equation
|
is the ratio of the
380-nm excitation signals of ionomycin-treated cells at 5 mM EGTA and
at 3 mM Ca2+ (17). Calibration of signals was
performed on samples of each culture preparation. In experiments with
newly isolated endothelial cells, the calibration protocol could not be
performed because the cells would detach during the medium changes.
Data were therefore expressed as ratio values of fura 2 fluorescence
only. Ca2+ changes in endothelial cells on aortic disks
were analyzed with the TILL Photonics imaging system adapted to an
upright fluorescence microscope (BX 50 WI, Olympus). The microscopic
focus was adjusted to the endothelial cell layer. Data were also
expressed as ratio values of fura 2 fluorescence.
Determination of Mn2+ influx. The influx of divalent cations via the endothelial plasma membrane was determined by Mn2+-induced quenching of fura 2 fluorescence. Fluorescence of fura 2-loaded cells was measured at the isosbestic wavelength of 360 nm (an excitation wavelength at which the fura 2 fluorescence is independent of cytosolic free [Ca2+]) in the presence of 1 mM Ca2+ with or without 100 µM MnCl2 in the incubation medium. Emitted light was detected at 510 nm and background corrected. To characterize the Mn2+-induced quench, the ratio between the slopes of the decline of fura 2 fluorescence after and before the addition of MnCl2 was determined (quench ratio). Mn2+ influx occurs when this quench ratio rises to values above 1.
Cellular ATP contents. Confluent endothelial monolayers cultured on 30-mm culture dishes were incubated under identical conditions as described for [Ca2+]i measurements. After removal of media, incubations were terminated by the addition of ice-cold perchloric acid (0.6 N). The ATP contents of neutralized extracts were determined by high-performance liquid chromatography according to Jüngling and Kammermeier (15). ATP contents (nM ATP/mg of cellular protein) were determined and were expressed as percentage of nonstimulated control dishes incubated for the same time. Protein contents were measured according to Bradford (3), with use of bovine serum albumin as standard.
Experimental protocols. To allow a comparison between Ca2+ development and the corresponding ATP depletion of endothelial monolayers, cells were treated identically in incubation. During the experiments, endothelial cells were incubated at 35°C in a HEPES-buffered solution composed of (in mM) 25 HEPES, 125 NaCl, 1.0 CaCl2, 2.6 KCl, 1.2 MgCl2, 1.2 KH2PO4, and pH 7.4 and supplemented with 2% (vol/vol) heat-inactivated NCS. To impair glycolytic or mitochondrial energy production, 2-deoxy-D-glucose (2-DG, 2.5-10 mM) or NaCN (1-5 mM) was added to media, respectively. In part of the experiments with 2-DG, pyruvate (5 mM) was added; in another part of the experiments with NaCN, glucose (10 mM) was added. Other agents were applied as indicated. Stock solutions of ionomycin, thapsigargin (THG), and xestospongin C (XeC) were prepared with dimethyl sulfoxide. XeC was applied 20 min before metabolic inhibition. Appropriate volumes of stock solutions were added to the cells yielding final solvent concentrations <0.1% (vol/vol). The same final concentration of dimethyl sulfoxide was also included in all respective control experiments. Stock solutions of all other substances were prepared in the specified HEPES-buffered solution. Appropriate volumes of these solutions were added to the cells. Identical additions were included in all respective control experiments.
Materials. Falcon plastic tissue culture dishes were from Becton-Dickinson (Heidelberg, Germany); fura 2-AM was from Molecular Probes (Eugene, OR); pyruvate and ATP were from Boehringer (Mannheim, Germany); ionomycin, ryanodine, THG, and XeC were from Calbiochem (Bad Soden, Germany); NaCN and glucose were from Merck (Darmstadt, Germany); 2-DG was from Sigma-Aldrich (Deisenhofen, Germany); NCS, medium 199, penicillin-streptomycin, and trypsin-EDTA were from GIBCO Life Technologies (Eggenstein, Germany). All other chemicals were of the best available quality, usually analytic grade.
Statistical analysis. Values are expressed as means ± SE of cells taken from at least three experiments using independent monolayer preparations. Statistical analysis was performed by one-way ANOVA in conjunction with the Student-Newman-Keuls test for post hoc analysis. Between-group analysis was performed, and P values <0.05 were considered significant.
| |
RESULTS |
|---|
|
|
|---|
Effect of 2-DG on [Ca2+]i.
Addition of the glycolysis inhibitor 2-DG to endothelial cells elicited
a biphasic rise of cytosolic Ca2+ (Fig.
1). [Ca2+]i
peaked at 1 min, declined afterward, and started to rise slowly again
after 3 min. This 2-DG-induced rise of
[Ca2+]i was dose dependent between 2.5 and 10 mM 2-DG. Higher concentrations of 2-DG did not augment
[Ca2+]i any further (data not shown). All
experiments following this study were performed with 2-DG at 10 mM.
|
|
|
Effect of NaCN on [Ca2+]i.
Addition of the mitochondrial inhibitor cyanide also caused a rapid and
dose-dependent increase in [Ca2+]i at
concentrations between 1 and 5 mM (Fig.
4). Higher concentrations of NaCN did not
augment [Ca2+]i any further (data not shown).
By using the pH indicator dye BCECF, we tested whether NaCN (5 mM)
alters cytosolic pH of the endothelial cells during the first 10 min
after the addition of NaCN. This was not the case (data not shown) and
in agreement with previous reports of others (30). As
observed in the case of 2-DG, NaCN caused a biphasic rise in
[Ca2+]i. It peaked 1 min after the addition
of cyanide showed a transient decline, and started to rise slowly
during the ongoing incubation period. Compared with the effect of 2-DG,
however, the maximum of the initial rise of
[Ca2+]i was smaller [145 ± 7 (NaCN 5 mM, n = 60) vs. 189 ± 7 (2-DG 10 mM,
n = 60); P < 0.05]. As in the case of
2-DG, it was analyzed whether NaCN stimulates influx of divalent
cations through the plasma membrane. The simultaneous addition of
MnCl2 (100 µM) with NaCN (5 mM) did not alter the decline
of the 360-nm fluorescence of fura 2 during the first 6 min, but did so
between 6 and 7 min after the addition of the inhibitor. The quench
rate rose from unity in the absence of NaCN to 2.2 ± 0.1 between
6 and 7 min after the addition of NaCN (n = 60, P < 0.05).
|
|
Metabolic inhibition of newly isolated endothelial cells and
endothelial cells in situ.
Part of the experiments described above for cultured endothelial
monolayers were repeated on newly isolated endothelial cells to explore
the possibility that the culturing may have changed the response of the
cells to metabolic inhibition. Changes of cytosolic Ca2+,
recorded in the ratio mode of fura 2 fluorescence, are depicted in Fig.
6A. The newly isolated cells
were submitted to the same protocols of 2-DG ± pyruvate or
NaCN ± glucose as described for cultured cells. The changes in
cytosolic Ca2+ control are qualitatively the same: 2-DG or
NaCN caused a rapid rise in [Ca2+]i,
indicated by the rise of the fura 2 ratio and the effect of 2-DG was
not suppressed by pyruvate, but the effect of NaCN was abolished by
glucose.
|
Cellular ATP contents.
To evaluate the effect of metabolic inhibitors on endothelial energy
production, ATP contents of cultured endothelial cells were determined
under the same conditions as specified for
[Ca2+]i measurements. Addition of either 2-DG
(10 mM) or NaCN (5 mM) alone caused a slight reduction of the cellular
ATP contents (Fig. 7). However, the
decrease in ATP contents did not reach significance during the first
minute of metabolic inhibition, i.e., in the period when the initial
[Ca2+]i rise reached its peak value. The loss
of ATP in the presence of 2-DG or NaCN was abolished when endothelial
cells were incubated in the additional presence of mitochondrial
(pyruvate 5 mM) or glycolytic (glucose 10 mM) substrates, respectively.
Note that the presence of pyruvate, however, did not attenuate the
2-DG-induced initial rise of [Ca2+]i (Fig.
3). Incubation of the cells in the simultaneous presence of both
metabolic inhibitors caused an early and marked fall in cellular ATP
contents.
|
Effect of THG pretreatment on 2-DG-induced rise in
[Ca2+]i.
We showed previously (20) that the initial rise of
[Ca2+]i in energy-depleted endothelial
monolayers is sensitive toward a pretreatment of cells with THG, an
inhibitor of the ER-Ca2+-ATPase (25), and that
this pretreatment empties the ER. We have now applied a low dose of THG
(10 nM) for a 15-min pretreatment of the cells that preempties the ER
so slowly that it does not cause a significant rise of the steady-state
[Ca2+]i. To test for the emptying of the ER,
ATP (10 µM) was added after the pretreatment. The cytosolic
[Ca2+]i rise elicited by ATP under control
conditions was suppressed by 71 ± 8% (n = 60).
After pretreatment with THG, the initial 2-DG-induced
[Ca2+]i rise was also markedly reduced (Fig.
8). This confirms the previous
observation that energy depletion causes a
[Ca2+]i rise by an effect on the
THG-sensitive ER.
|
Effect of ER-Ca2+-ATPase inhibitors on 2-DG-induced
rise in [Ca2+]i.
In the next set of experiments, THG (10 nM) was not used for
pretreatment but applied simultaneously with 2-DG to inhibit the
ER-Ca2+-ATPase with the onset of metabolic inhibition. As
illustrated in Fig. 9 the presence of the
ATPase-inhibitor accelerated and augmented the 2-DG-induced
[Ca2+]i overload. Note that THG (10 nM) had no effect on [Ca2+]i when
applied in the absence of 2-DG (Fig. 8). The time course of the
[Ca2+]i overload was also altered in the
copresence of THG and 2-DG (Fig. 9) compared with the time course in
the presence of 2-DG alone; the typical transient drop in
[Ca2+]i, after its initial rise, was
virtually abolished. Instead, [Ca2+]i stayed
elevated. Analogous experiments, as here described for THG, were also
performed with cyclopiazonic acid (CPA, 1 µM), a structurally
different inhibitor of the ER-Ca2+-ATPase
(18). The same changes were observed (Fig.
10). THG and CPA increased the maximum
rate of the initial rise of [Ca2+]i and
slowed down the subsequent transient decline of
[Ca2+]i.
|
|
Effect of XeC on rise in [Ca2+]i. The ER of endothelial cells can release Ca2+ through Ins(3)P-dependent release channels, but the presence of ryanodine-sensitive Ca2+ release channels has also been identified on the functional level (31). Inhibition of the latter with ryanodine had no effect on the 2-DG-induced initial rise of [Ca2+]i compared with 2-DG alone [180 ± 7 nM (ryanodine 25 µM + 2-DG 10 mM, n = 60) vs. 185 ± 6 nM (2-DG 10 mM alone, n = 60), P > 0.05].
We then tested whether the presence of the inhibitor of the Ins(3)P-dependent Ca2+-release channel XeC (8) alters the 2-DG-induced [Ca2+]i rise. In control experiments, we found that XeC at 3 µM suppressed the ATP (10 µM)-induced rise in [Ca2+]i by 94 ± 4% (n = 60). Preincubation (20 min) of endothelial monolayers with XeC at 3 µM abolished the 2-DG-induced [Ca2+]i increase (Fig. 11). This result indicates that the [Ca2+]i rise is due to a release of Ca2+ from the ER through Ins(3)P-dependent Ca2+-release channels.
|
| |
DISCUSSION |
|---|
|
|
|---|
The findings of our study show that endothelial cells react sensitively to inhibition of glycolytic energy production. This mechanism was demonstrated here for cultured and freshly isolated endothelial cells as well as for endothelial cells in situ on the intact aortic vessel wall. Analysis of the mechanism reveal that glycolytic inhibition leads to a sudden release of endoplasmic-stored Ca2+ through an opening of Ins(3)P-dependent release channels. At the same time, the Ca2+-ATPase of the ER remains functionally active. Blockade of this endogenous Ca2+ release with XeC prevents the early and the delayed rise of [Ca2+]i.
On energy depletion, porcine aortic endothelial cells responded with a biphasic rise of [Ca2+]i, very similar to that described for coronary endothelial cells from the rat (20). The first phase lasts for a few minutes, with the peak [Ca2+]i occurring around 1 min after the addition of metabolic inhibitors. This initial phase is sensitive to a pretreatment of the cells with THG, which empties the ER. Mn2+-quenching experiments show that the transplasmalemmal flux of these divalent cations is not enhanced during the initial phase of metabolic inhibition, indicating there is no increased Ca2+ influx at this time. These findings corroborate the conclusion from previous experiments on coronary endothelial cells (20) and rat aortic endothelial cells (30) that the Ca2+ accumulating in the cytosol on metabolic inhibition originates initially from the ER. The mechanisms by which the Ca2+ load of the ER becomes diminished previously remained unclear.
In experiments of the present study in which inhibitors of ER-Ca2+-ATPase, THG, or CPA were given simultaneously with the metabolic inhibitor, the initial, sudden rise of [Ca2+]i became steeper and larger, and the transient secondary fall of [Ca2+]i was nearly abolished. This shows that metabolic inhibition leads to an initial activation of the ER-Ca2+-ATPase, inhibited in the presence of THG as well as of CPA. This activation of the ER-Ca2+-ATPase blunts an otherwise higher rise of [Ca2+]i and even reverses some of the initial cytosolic Ca2+ overload. This finding has consequences for the causal understanding of the initiation of the ER-dependent rise of cytosolic Ca2+. This [Ca2+]i rise can either be due to a reduction in Ca2+ uptake into the ER or an increase in Ca2+ release from the ER. Because the Ca2+ uptake is not found inactivated, the [Ca2+]i rise must be due to an augmented release from the ER.
We analyzed the nature of this release mechanism with use of specific inhibitors. Ryanodine had no effect, but XeC, a potent inhibitor of the Ins(3)P-sensitive release channel that displays high selectivity over ryanodine receptors (8), blocked the rise of [Ca2+]i elicited by metabolic inhibition. This indicates that the Ins(3)P-sensitive release channel is responsible for the release.
The initial sudden rise of [Ca2+]i, due to Ca2+ release from the ER, occurred at a time when changes in total endothelial contents of ATP were small and insignificant. This is in agreement with previous observations in coronary endothelial cells (20). At high drug concentrations, Ca2+ release could be provoked both by inhibitors of oxidative energy production and of glycolytic energy production. But the response was much more sensitive to inhibition of glycolytic energy production. This is because the effect of mitochondrial inhibition could be blunted by the administration of glucose as a substrate for glycolysis, in agreement with Shimizu and Paul (22), and because the effect of glycolytic inhibition could not be reduced by the administration of pyruvate as mitochondrial substrate. It is worth noting that in the presence of 2-DG and pyruvate, total cellular ATP contents remained absolutely unaltered for the entire duration of the experiments, whereas [Ca2+]i still rose. This specific sensitivity of endoplasmic Ca2+ release to inhibition of glycolytic energy production may be due to local changes in ATP concentration at the ER, because the cascade of glycolytic enzymes is associated with ER membranes (29). For other cells, the Ins(3)P-sensitive Ca2+ release channel may become sensitized at low concentrations of ATP (6, 23). It seems possible that such a sensitization causes an increased opening probability of the channel also in metabolically inhibited endothelial cells. It is also possible that synthesis of Ins(3)P may be rapidly upregulated on metabolic inhibition.
After the first peak, [Ca2+]i declines transiently and then rises again, progressively. Mn2+-quenching experiments reveal that transplasmalemmal Ca2+ influx starts with this second progressive rise in [Ca2+]i. These results are in agreement with those obtained by Noll et al. (20) who showed that the second, but not the first, phase of [Ca2+]i rise is abolished when extracellular Ca2+ is removed at the time of metabolic inhibition. In agreement with these previous results, we now observed that the delayed rise of cytosolic Ca2+ can be suppressed by the addition of Ni2+ to extracellular medium just after the peak of the initial rise. XeC applied at this point in time had no effect on the delayed rise. It abolished the delayed rise, however, when the ability of the ER to release Ca2+ was initially blocked. This demonstrates that the Ca2+ influx causing the second rise of [Ca2+]i is dependent indirectly on Ca2+ discharge from the ER. It seems likely that the second rise of Ca2+ is due to the activation of store-operated transplasmalemmal Ca2+ influx as is also observed in endothelial cells in response to various receptor agonists. These results are in apparent contrast to those obtained from rat aortic endothelial cells under metabolic inhibition by Ziegelstein et al. (30). These authors observed a uniformly progressive rise of [Ca2+]i, lacking the sudden initial component here described. They found that this progressive rise was sensitive to THG pretreatment but insensitive to removal of external Ca2+. They concluded it was directly due to Ca2+ leakage from the ER. It is unclear whether this discrepancy of results is due to differences in experimental procedure or cell species.
The sudden release of Ca2+ from the ER initiated by glycolytic inhibition represents a very sensitive reaction of endothelial cells to ischemic conditions. In ischemic-reperfused tissue, a number of factors can act on endothelial cells able to inhibit glycolysis. Among these are acidosis, increased concentrations of lactate, and oxygen radicals (13, 28). It is conceivable that the rapid response of endothelial [Ca2+]i to glycolytic inhibition acts as a physiological sensor for metabolic disturbance in the surrounding tissue. Rise of cytosolic Ca2+ in endothelial cells leads to an increase in transendothelial permeability (5, 20), which facilities exchange of substances across this barrier, but also promotes interstitial edema. Emptying of the Ca2+ load of the ER may also be responsible for the reduced response to endothelium-dependent vasodilators observed by some authors after prolonged glycolytic inhibition (10, 27). This is because these mediators depend on a Ca2+-induced activation of NO synthase. The same authors (10, 27) failed to see an endothelium-dependent vasodilatation on the addition of 2-DG alone. It is unclear how these latter findings relate to the observation made in the present study, i.e., that cytosolic Ca2+ rises in response to 2-DG. The following explanations seem possible. First, as argued by Griffith et al. (11), 2-DG may have inhibitory effects on NO synthesis, and these are independent of Ca2+. Second, in the vessels investigated in those cited studies (10, 27), the endothelial Ca2+ response to 2-DG may have been smaller than the one found in the models here described.
In conclusion, this study shows that endothelial cells react sensitively to changes in glycolytic energy production with Ca2+ release from ER. Because many functions of endothelial cells, including their production of vasoactive mediators and their function in forming a permeability barrier, are triggered by changes in the cytosolic [Ca2+], this mechanism seems of pathophysiological significance. The fact that under energy depletion the initial rise of [Ca2+]i, which is also responsible for the later sustained [Ca2+]i overload of endothelial cells, can be inhibited by XeC, a blocker of Ins(3)P-release channels, may give rise to new therapeutic strategies.
| |
ACKNOWLEDGEMENTS |
|---|
This work was supported by the Deutsche Forschungsgemeinschaft, Grants A3 and A4 of Sonderforschungsbereich 547.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: M. Schäfer, Physiologisches Institut, Justus-Liebig-Universität, Aulweg 129, D-35392 Giessen, Germany (E-mail: Matthias.Schaefer{at}physiologie.med.uni-giessen.de).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 27 September 1999; accepted in final form 15 September 2000.
| |
REFERENCES |
|---|
|
|
|---|
1.
Ando, J,
Komatsuda T,
and
Kamiya A.
Cytoplasmic calcium response to fluid shear stress in cultured vascular endothelial cells.
In Vitro Cell Dev Biol
24:
871-877,
1988[Web of Science][Medline].
2.
Arnould, T,
Michiels C,
Alexandre I,
and
Remacle J.
Effect of hypoxia upon intracellular calcium concentration of human endothelial cells.
J Cell Physiol
152:
215-221,
1992[Web of Science][Medline].
3.
Bradford, MM.
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
Anal Biochem
72:
248-254,
1976[Web of Science][Medline].
4.
Carson, MR,
Shasby SS,
and
Shasby DM.
Histamine and inositol phosphate accumulation in endothelium: cAMP and a G protein.
Am J Physiol Lung Cell Mol Physiol
257:
L259-L264,
1989
5.
Curry, FE.
Modulation of venular microvessel permeability by calcium influx into endothelial cells.
FASEB J
6:
2456-2466,
1992[Abstract].
6.
Ferris, CD,
Hunganir RL,
and
Snyder SH.
Calcium flux mediated by purified inositol 1,4,5-trisphosphate receptor in reconstituted lipid vesicles is allosterically regulated by adenine nucleotides.
Proc Natl Acad Sci USA
87:
2147-2151,
1989
7.
Furchgott, RF,
and
Vanhoutte PM.
Endothelium-derived relaxing and contracting factors.
FASEB J
3:
2007-2018,
1993[Abstract].
8.
Gafni, J,
Munsch JA,
Lam TH,
Catlin MC,
Costa LG,
Molinski TF,
and
Pessah IN.
Xestospongins: potent membrane permeable blockers of the inositol 1,4,5-trisphosphate receptor.
Neuron
19:
723-733,
1997[Web of Science][Medline].
9.
Garcia, JG,
Davis HW,
and
Patterson CE.
Regulation of endothelial cell gap formation and barrier dysfunction: role of myosin light chain phosphorylation.
J Cell Physiol
163:
510-522,
1995[Web of Science][Medline].
10.
Griffith, TM,
Edwards DH,
and
Henderson AH.
Unstimulated release of endothelium derived relaxing factor is independent of mitochondrial ATP generation.
Cardiovasc Res
21:
565-568,
1987[Web of Science][Medline].
11.
Griffith, TM,
Edwards DH,
Newby AC,
Lewis MJ,
and
Henderson AH.
Production of endothelium derived relaxant factor is dependent on oxidative phosphorylation and extracellular calcium.
Cardiovasc Res
20:
7-12,
1986[Web of Science][Medline].
12.
Grynkiewicz, G,
Poenie M,
and
Tsien RY.
A new generation of Ca2+ indicators with greatly improved fluorescence properties.
J Biol Chem
260:
3440-3450,
1985
13.
Hyslop, PA,
Hinshaw DB,
Halsey WA, Jr,
Schraufstätter IU,
Sauerheber RD,
Spragg RG,
Jackson JH,
and
Cochrane CG.
Mechanisms of oxidant-mediated cell injury: the glycolytic and mitochondrial pathways of ADP phosphorylation are major intracellular targets inactivated by hydrogen peroxide.
J Biol Chem
263:
1665-1675,
1988
14.
Jaffe, EA,
Grulich J,
Weksler BB,
Hampel G,
and
Watanabe K.
Correlation between thrombin-induced prostacyclin production and inositol trisphosphate and cytosolic free calcium levels in cultured human endothelial cells.
J Biol Chem
262:
8557-8565,
1987
15.
Jüngling, E,
and
Kammermeier H.
Rapid assay of adenine nucleotides or creatine compounds in extracts of cardiac tissue by paired-ion reversed-phase high performance liquid chromatography.
Anal Biochem
102:
358-361,
1980[Web of Science][Medline].
16.
Ladilov, YV,
Siegmund B,
Balser C,
and
Piper HM.
Stimulated ischemia increases the susceptibility of rat cardiomyocytes to hypercontracture.
Circ Res
80:
69-75,
1997
17.
Li, Q,
Altschuld A,
and
Stokes BT.
Quantification of intracellular free calcium in single adult cardiomyocytes by fura-2 fluorescence microscopy: calibration of fura-2 ratios.
Biochem Biophys Res Commun
147:
120-126,
1987[Web of Science][Medline].
18.
Mason, MJ,
Garcia-Rodriguez C,
and
Grinstein S.
Coupling between intracellular Ca2+ stores and the Ca2+ permeability of the plasma membrane: comparison of the effects of thapsigargin, 2,5-di(tert-butyl)-1,4-hydroquinone, and cyclopiazonic acid in rat thymic lymphocytes.
J Biol Chem
266:
20856-20882,
1991
19.
Muhs, A,
Noll T,
and
Piper HM.
Vinculin phosphorylation and barrier failure of coronary endothelial monolayers under energy depletion.
Am J Physiol Heart Circ Physiol
273:
H608-H617,
1997
20.
Noll, T,
Muhs A,
Besselmann M,
Watanabe H,
and
Piper HM.
Initiation of hyperpermeability in energy-depleted coronary endothelial monolayers.
Am J Physiol Heart Circ Physiol
268:
H1462-H1470,
1995
21.
Shen, J,
Luscinskas FW,
Connolly A,
Dewey CF, Jr,
and
Gimbrone MA, Jr.
Fluid shear stress modulates cytosolic free calcium in vascular endothelial cells.
Am J Physiol Cell Physiol
262:
C384-C390,
1992
22.
Shimizu, S,
and
Paul RJ.
Hypoxia and alkalinization inhibit endothelium-derived nitric oxide but not endothelium-derived hyperpolarizing factor responses in porcine coronary artery.
J Pharmacol Exp Ther
291:
335-344,
1999
23.
Smith, JB,
Smith L,
and
Higgins BL.
Temperature and nucleotide dependence of calcium release by myo-inositol 1,4,5-trisphosphate in cultured vascular smooth muscle cells.
J Biol Chem
260:
14413-14416,
1985
24.
Spahr, R,
and
Piper HM.
Microcarrier cultures of endothelial cells.
In: Cell Culture Techniques in Heart and Vessel Research, edited by Piper HM.. Heidelberg: Springer-Verlag, 1990, p. 220-229.
25.
Thastrup, O,
Cullen PJ,
Drobak BK,
Hanley MR,
and
Dawson AP.
Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2+-ATPase.
Proc Natl Acad Sci USA
87:
2466-2470,
1990
26.
Unno, N,
Menconi MJ,
Salzman AL,
Smith M,
Hagen S,
Ge Y,
Ezzell RM,
and
Fink MP.
Hyperpermeability and ATP depletion induced by chronic hypoxia or glycolytic inhibition in Caco-BBE monolayers.
Am J Physiol Gastrointest Liver Physiol
270:
G1010-G1021,
1996
27.
Weir, CJ,
Gibson IF,
and
Martin W.
Effects of metabolic inhibitors on endothelium-dependent and endothelium-independent vasodilatation of rat and rabbit aorta.
Br J Pharmacol
102:
162-166,
1991[Web of Science][Medline].
28.
Wilson, J,
Winter M,
and
Shasby DM.
Oxidants, ATP depletion and endothelial permeability to macromolecules.
Blood
76:
2578-2582,
1990
29.
Xu, KY,
Zweier JL,
and
Becker LC.
Functional coupling between glycolysis and sarcoplasmic reticulum Ca2+ transport.
Circ Res
77:
88-97,
1995
30.
Ziegelstein, RC,
Cheng L,
Aversano T,
Ouyang P,
Lakatta EG,
and
Silverman HS.
Increase in rat aortic endothelial free calcium mediated by metabolically sensitive calcium release from endoplasmic reticulum.
Cardiovasc Res
28:
1433-1439,
1994
31.
Ziegelstein, RC,
Spurgeon HA,
Pili R,
Passaniti A,
Cheng L,
Corda S,
Lakatta EG,
and
Capogrossi MC.
A functional ryanodine-sensitive intracellular Ca2+ store is present in vascular endothelial cells.
Circ Res
74:
151-156,
1994
32.
Zhou, X,
Zhai X,
and
Ashraf M.
Preconditioning of bovine endothelial cells: the protective effect is mediated by an adenosine A2 receptor through a protein kinase C signaling pathway.
Circ Res
78:
73-81,
1996
This article has been cited by other articles:
![]() |
S. A. Kasseckert, C. Schafer, A. Kluger, D. Gligorievski, J. Tillmann, K.-D. Schluter, T. Noll, H. Sauer, H. M. Piper, and Y. Abdallah Stimulation of cGMP signalling protects coronary endothelium against reperfusion-induced intercellular gap formation Cardiovasc Res, July 15, 2009; 83(2): 381 - 387. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Aromolaran, A. V. Zima, and L. A. Blatter Role of glycolytically generated ATP for CaMKII-mediated regulation of intracellular Ca2+ signaling in bovine vascular endothelial cells Am J Physiol Cell Physiol, July 1, 2007; 293(1): C106 - C118. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Abdallah, D. Gligorievski, S. A. Kasseckert, L. Dieterich, M. Schafer, C. R. Kuhlmann, T. Noll, H. Sauer, H.M. Piper, and C. Schafer The role of poly(ADP-ribose) polymerase (PARP) in the autonomous proliferative response of endothelial cells to hypoxia Cardiovasc Res, February 1, 2007; 73(3): 568 - 574. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Schafer, S. Walther, M. Schafer, L. Dieterich, S. Kasseckert, Y. Abdallah, and H.M. Piper Inhibition of contractile activation reduces reoxygenation-induced endothelial gap formation Cardiovasc Res, April 1, 2003; 58(1): 149 - 155. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |